Published on in Vol 11, No 5 (2022): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35969, first published .
Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Cristian Garcia 1, BSc;  Nadia Rehman 1, BDS;  Daeria O Lawson 1, HBSc;  Pascal Djiadeu 1, PhD;  Lawrence Mbuagbaw 1, 2, 3, 4, 5, MPH, MD, PhD

1 Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, ON, CA

2 Department of Anesthesia, McMaster University , Hamilton, ON, CA

3 Department of Pediatrics, McMaster University , Hamilton, ON, CA

4 Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare, Hamilton, ON, CA

5 Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town , ZA

Corresponding Author: